Organization

NYU Langone Medical Center

7 abstracts

Abstract
Predicting completion of endocrine therapy for older patients with early-stage breast cancer.
Org: NYU Langone Medical Center, Perlmutter Cancer Center, New York University Langone Health, NYU Langone Health,
Abstract
Predictive cytokine biomarkers for immune-related adverse events associated with immune checkpoint inhibitor therapy in Hodgkin lymphoma.
Org: NYU Langone Medical Center, NYU Langone Health, New York, NY, Perlmutter Cancer Center, New York University Langone Health,
Abstract
Safety of tabelecleucel with pembrolizumab in recurrent/metastatic Epstein–Barr virus-associated nasopharyngeal carcinoma.
Org: Stanford Cancer Center, University of Pennsylvania, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, City of Hope Comprehensive Cancer Center Department of Medical Oncology and Therapeutics Research,
Abstract
Meta-analyses of factors associated with long-term survival after resection of pancreatic ductal adenocarcinoma.
Org: Aga Khan University Hospital, NYU Langone Medical Center, The Aga Khan University, University of Maryland School of Medicine, NYU Langone Health, New York, NY,
Abstract
CAN-2409 plus prodrug with standard of care immune checkpoint inhibitor for patients with stage III/IV NSCLC.
Org: University of Pennsylvania, NYU Langone Medical Center, Vanderbilt University Medical Center, University of Chicago, Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic,
Abstract
ADHERENCE TO HYDROXYCHLOROQUINE AS ASSESSED BY MEASUREMENTS OF DRUG AND METABOLITE BLOOD LEVELS IN AN INTERNATIONAL PROSPECTIVE STUDY OF SLE PATIENTS IN FLARE
Org: Cochin Hospital, Cliniques Universitaires Saint-Luc, NYU Langone Medical Center, University of Santo Tomas Hospital - Benavides Cancer Institute, Rush University Medical Center,